Resultados da pesquisa - Alberto Lleó

Refinar resultados
  1. 1
    Current Therapeutic Options for Alzheimers Disease

    Current Therapeutic Options for Alzheimers Disease Por Alberto Lleó

    Publicado em 2007
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Cognitive symptoms after COVID-19

    Cognitive symptoms after COVID-19 Por Miren Altuna, Ma Belén Sánchez‐Saudinós, Alberto Lleó

    Publicado em 2021
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets

    APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets Por Sònia Sirisi, Érika Sánchez‐Aced, Olivia Belbin, Alberto Lleó

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  4. 4
    Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease

    Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease Por Juan Ramón Perea, Alberto Lleó, Daniel Alcolea, Juan Fortea, Jesús Ávila, Marta Bolós

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Familial Alzheimer's Disease Presenilin 1 Mutations Cause Alterations in the Conformation of Presenilin and Interactions with Amyloid Precursor Protein

    Familial Alzheimer's Disease Presenilin 1 Mutations Cause Alterations in the Conformation of Presenilin and Interactions with Amyloid Precursor Protein Por Oksana Berezovska, Alberto Lleó, Lauren Herl, Matthew P. Frosch, Edward A. Stern, Brian J. Bacskai, Bradley T. Hyman

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    O3‐06‐06: ANTI‐Aβ AUTOANTIBODIES IN CAA AND AD: DIFFERENT SINGERS FOR THE SAME ARIA?

    O3‐06‐06: ANTI‐Aβ AUTOANTIBODIES IN CAA AND AD: DIFFERENT SINGERS FOR THE SAME ARIA? Por Fabrizio Piazza, Steven M. Greenberg, Alberto Lleó, Carlo Ferrarese, Ricardo Nitríni, Fabrizio Tagliavini, Jacopo C. DiFrancesco

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome

    Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome Por Aurélie Ledreux, María Carmona‐Iragui, Laura Videla, Bessy Benejam, Isabel Barroeta, Alberto Lleó, Daniel Alcolea, Juan Fortea

    Publicado em 2025
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies

    Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies Por Martí Colom‐Cadena, Ellen Gelpí, Sara Charif, Olivia Belbin, Rafael Blesa, Maria José Martí, Jordi Clarimón, Alberto Lleó

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Clinical and video-polysomnographic analysis of rapid eye movement sleep behavior disorder and other sleep disturbances in dementia with Lewy bodies

    Clinical and video-polysomnographic analysis of rapid eye movement sleep behavior disorder and other sleep disturbances in dementia with Lewy bodies Por Ana Fernández‐Arcos, Estrella Morenas‐Rodríguez, Joan Santamaría, Raquel Sánchez‐Valle, Albert Lladó, Carles Gaig, Alberto Lleó, Álex Iranzo

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies

    YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies Por Marta Querol‐Vilaseca, Martí Colom‐Cadena, Jordi Pegueroles, Carla San Martín-Paniello, Jordi Clarimón, Olivia Belbin, Juan Fortea, Alberto Lleó

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production

    The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production Por Nahuai Badiola, Víctor Alcalde, Albert Juncà i Pujol, Lisa Marie Munter, Gerd Multhaup, Alberto Lleó, Mireia Coma, Montserrat Soler‐López, Patrick Aloy

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease

    Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease Por Eduard Vilaplana, E. Rodriguez-Vieitez, Daniel Ferreira, Víctor Montal, Ove Almkvist, Anders Wall, Alberto Lleó, Eric Westman, Caroline Graff, Juan Fortea, Agneta Nordberg

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy

    Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy Por Nahuai Badiola, Rita Machado de Oliveira, Federico Herrera, Cristina Guardia‐Laguarta, S. Gonçalves, Marta Pera, Marc Suárez‐Calvet, Jordi Clarimón, Tiago F. Outeiro, Alberto Lleó

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Clinical, Neuropathologic, and Biochemical Profile of the Amyloid Precursor Protein I716F Mutation

    Clinical, Neuropathologic, and Biochemical Profile of the Amyloid Precursor Protein I716F Mutation Por Cristina Guardia‐Laguarta, Marta Pera, Jordi Clarimón, José Luís Molinuevo, Raquel Sánchez‐Valle, Albert Lladó, Mireia Coma, Teresa Gómez‐Isla, Rafael Blesa, Isidró Ferrer, Alberto Lleó

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

    New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia Por Marta del Campo, Henrik Zetterberg, Sam Gandy, Chiadi U. Onyike, Fabricio Ferreira de Oliveira, Chinedu Udeh‐Momoh, Alberto Lleó, Charlotte E. Teunissen, Yolande A.L. Pijnenburg

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  16. 16
    Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice

    Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice Por Ángel Trueba-Sáiz, Carmen Cavada, Ana M. Fernández, Thomas Y.Y. Leon, Débora A. González, Juan Fortea, Alberto Lleó, Teodoro del Ser, Ángel Núñez, Ignacio Torres‐Alemán

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    -Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1

    -Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1 Por Jorge Castejón España, Jorge Valero, Alfredo J. Miñano‐Molina, Roser Masgrau, Elodie Martin, Cristina Guardia‐Laguarta, Alberto Lleó, Lydia Giménez‐Llort, José Rodrı́guez-Álvarez, Carlos A. Saura

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration

    Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration Por David J. Irwin, Alberto Lleó, Sharon X. Xie, Corey T. McMillan, David A. Wolk, Edward B. Lee, V.M. Van Deerlin, Leslie M. Shaw, John Q. Trojanowski, Murray Grossman

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes

    A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes Por Alberto Lleó, David J. Irwin, Ignacio Illán‐Gala, Corey T. McMillan, David A. Wolk, Edward B. Lee, Vivianna M. Van Deerlin, Leslie M. Shaw, John Q. Trojanowski, Murray Grossman

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

    Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease Por Dolores Siedlecki‐Wullich, Judit Català-Solsona, Cristina Fábregas, Isabel de la Torre Díez, Jordi Clarimón, Alberto Lleó, Merçé Boada, Carlos A. Saura, José Rodrı́guez-Álvarez, Alfredo J. Miñano‐Molina

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: